Amphastar Pharmaceuticals, Inc. - COM (AMPH)

Historical Portfolio Holders from Q2 2014 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
33.5 M
Holdings value Q1 2024
$1.47 B
Value change Q1 2024
+$456 K
Grand Portfolio weight change Q1 2024
+0%
Number of holders
263
Number of buys Q1 2024
4
Number of sells Q1 2024
-6
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
03209R103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 29.8 K $1.2 M -$494 K $40.00 13
2024 Q1 33.5 M $1.47 B +$456 K $43.91 263
2023 Q4 33 M $2.04 B +$86.5 M $61.85 271
2023 Q3 32 M $1.47 B +$23 M $45.99 250
2023 Q2 31.4 M $1.8 B +$77.8 M $57.47 239
2023 Q1 30.1 M $1.13 B +$45.7 M $37.50 214
2022 Q4 29 M $814 M -$16.7 M $28.02 204
2022 Q3 28.8 M $808 M -$34.1 M $28.10 190
2022 Q2 30.3 M $1.05 B +$37.3 M $34.79 213
2022 Q1 29.6 M $1.06 B +$25.7 M $35.90 198
2021 Q4 29 M $675 M +$19.6 M $23.29 162
2021 Q3 27.9 M $530 M +$12.4 M $19.01 134
2021 Q2 27.1 M $547 M +$26.4 M $20.16 139
2021 Q1 26 M $476 M +$861 K $18.32 129
2020 Q4 25.9 M $521 M -$3.1 M $20.11 123
2020 Q3 26.1 M $490 M -$4.98 M $18.75 129
2020 Q2 26.3 M $591 M +$55 M $22.46 129
2020 Q1 23.8 M $353 M -$14.1 M $14.84 100
2019 Q4 24.5 M $473 M +$9.59 M $19.29 114
2019 Q3 24.1 M $477 M +$39.2 M $19.83 128
2019 Q2 22.3 M $470 M +$11.9 M $21.11 124
2019 Q1 22.4 M $458 M +$3.94 M $20.43 131
2018 Q4 22.1 M $440 M +$30.7 M $19.90 127
2018 Q3 20.6 M $397 M +$11.9 M $19.24 103
2018 Q2 20.1 M $307 M -$10 M $15.26 107
2018 Q1 20.7 M $388 M +$4.44 M $18.75 114
2017 Q4 20.6 M $397 M +$7.33 M $19.24 103
2017 Q3 20.2 M $362 M -$3.14 M $17.87 99
2017 Q2 20.4 M $365 M +$4.54 M $17.86 106
2017 Q1 20.4 M $296 M +$42.3 M $14.50 113
2016 Q4 22.3 M $412 M +$7.35 M $18.42 134
2016 Q3 22.2 M $421 M +$115 M $18.97 134
2016 Q2 16.2 M $261 M +$32.1 M $16.12 105
2016 Q1 14.3 M $171 M -$8.85 M $12.00 94
2015 Q4 14.7 M $210 M +$12.9 M $14.23 93
2015 Q3 12.1 M $141 M -$3.14 M $11.69 90
2015 Q2 13.3 M $234 M +$48.8 M $17.58 85
2015 Q1 10.6 M $158 M +$40.4 M $14.96 57
2014 Q4 7.81 M $90.7 M +$5.4 M $11.61 53
2014 Q3 7.24 M $84.4 M +$80.9 M $11.64 44
2014 Q2 300 K $3 M +$3 M $10.01 2